WTG
WST icon

West Tower Group’s West Pharmaceutical WST Stock Holding History

West Tower Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-301
Closed -$106K – 506
2023
Q4 		$106K Buy
301
+82
+37% +$29K 0.22% 67
2023
Q3 		$82.2K Buy
219
+195
+813% +$75.4K 0.04% 122
2023
Q2 		$9.18K Buy
+24
New +$8.57K 0.01% 444

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

West Tower Group's WST Position: Q1 2024 in Review

West Tower Group sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 301 shares — an estimated $106K sold.

West Tower Group first reported a position in WST in Q2 2023 and held it in 3 quarters. The position peaked at $106K in Q4 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • West Tower Group reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • West Tower Group sold 301 West Pharmaceutical shares in Q1 2024, an estimated $106K.
  • West Tower Group first reported a position in West Pharmaceutical in Q2 2023 and held it in 3 quarters.
  • West Tower Group's West Pharmaceutical position peaked at $106K in Q4 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.